トップ > 販売中止製品一覧
製品タイプ（9890）
| Code No. | 製品名 | 販売中止日 | メーカー |
|---|---|---|---|
| TS-0008-1C | T-Select HLA-A*02:01 HIV pol Tetramer-ILKEPVHGV-PE | 2024/03/25 | MBL |
| TS-0013-1C | T-Select HLA-A*02:01 gp100 (mutant) Tetramer-IMDQVPFSV-PE | 2024/03/25 | MBL |
| TS-0014-1C | T-Select HLA-A*02:01 gp100 (wild) Tetramer-ITDQVPFSV-PE | 2024/03/25 | MBL |
| TS-0025-1C | T-Select HLA-B*07:02 CMV pp65 Tetramer-TPRVTGGGAM-PE | 2024/03/25 | MBL |
| TS-M067-1 | HLA-B*35:01 AdV Hexon 320-329 Tetramer-MPNRPNYIAF-PE | 2024/03/25 | MBL |
| TS-M068-1 | HLA-B*35:01 AdV Hexon 705-713 Tetramer-IPYLDGTFY-PE | 2024/03/25 | MBL |
| TS-M120-1 | HLA-A*02:01 PSA141-150 Tetramer-FLTPKKLQCV-PE | 2024/03/25 | MBL |
| TS-M536-2 | H-2Dd HIV env Tetramer-IGPGRAFYA-APC | 2024/03/25 | MBL |
| TB-7300-K4 | QuickSwitch™ Quant HLA-A*02:01 Tetramer Kit-BV421 | 2022/06/01 | MBLI |
| TS-5002-2C | T-Select H-2Db LCMV gp33 Tetramer-KAVYNFATC-APC | 2022/04/25 | MBL |
| TS-M055-2 | HLA-B*35:01 HIV RT Tetramer-NPDIVIYQY-APC | 2022/04/25 | MBL |
| TB-7305-K1 | QuickSwitch™ HLA-A*11:01 Tetramer Kit-PE | 2020/09/15 | MBLI |
| TB-7305-K2 | QuickSwitch™ HLA-A*11:01 Tetramer Kit-APC | 2020/09/15 | MBLI |
| TB-7305-K4 | QuickSwitch™ HLA-A*11:01 Tetramer Kit-BV421 | 2020/09/15 | MBLI |
| TB-7303-K4 | QuickSwitch™ HLA-A*24:02 Tetramer Kit-BV421 | 2020/09/15 | MBLI |
| TB-7303-K1 | QuickSwitch™ HLA-A*24:02 Tetramer Kit-PE | 2020/09/15 | MBLI |
| TB-7401-K4 | QuickSwitch™ H-2Kb Tetramer Kit-BV421 | 2020/09/15 | MBLI |
| TB-7401-K2 | QuickSwitch™ H-2Kb Tetramer Kit-APC | 2020/09/15 | MBLI |
| TB-7401-K1 | QuickSwitch™ H-2Kb Tetramer Kit-PE | 2020/09/15 | MBLI |
| TB-7301-K4 | QuickSwitch™ HLA-A*02:01 Tetramer Kit-BV421 | 2020/09/15 | MBLI |
| TB-7301-K2 | QuickSwitch™ HLA-A*02:01 Tetramer Kit-APC | 2020/09/15 | MBLI |
| TB-7301-K1 | QuickSwitch™ HLA-A*02:01 Tetramer Kit-PE | 2020/09/15 | MBLI |
| TB-7303-K2 | QuickSwitch™ HLA-A*24:02 Tetramer Kit-APC | 2019/12/27 | MBLI |
| TB-7302-K2 | QuickSwitch™ Quant HLA-A*24:02 Tetramer Kit-APC | 2019/12/17 | MBLI |
| TB-M951-1 | BF2*1201 IBDV VP2 Tetramer-ALRPVTLV-PE | 2019/07/22 | MBLI |
| TB-M951-2 | BF2*1201 IBDV VP2 Tetramer-ALRPVTLV-APC | 2019/07/22 | MBLI |
| TS-M086-1 | HLA-A*02:01 IDO Tetramer-ALLEIASCL-PE | 2019/07/01 | MBL |
| TS-M086-2 | HLA-A*02:01 IDO Tetramer-ALLEIASCL-APC | 2019/07/01 | MBL |
| TS-M075-1 | HLA-A*02:01 MAGE-A3 112-120 Tetramer-KVAELVHFL-PE | 2018/12/04 | MBL |
| TS-M075-2 | HLA-A*02:01 MAGE-A3 112-120 Tetramer-KVAELVHFL-APC | 2018/12/04 | MBL |
| TS-M057-1 | HLA-A*02:01 CMV IE1 316-324 Tetramer-VLEETSVML-PE | 2018/11/28 | MBL |
| TS-0029-1C | T-Select HLA-A*02:01 Negative Tetramer-PE | 2018/11/22 | MBL |
| TS-M076-1 | HLA-A*02:01 MAGE-A3 271-279 Tetramer-FLWGPRALV-PE | 2018/11/16 | MBL |
| TS-M537-2 | H-2Kb HBV core Tetramer-MGLKFRQL-APC | 2018/06/26 | MBL |
| TS-5010-1C | H-2Kb LCMV gp34-41 Tetramer-AVYNFATC-PE | 2018/02/14 | MBL |
| TS-5010-2C | H-2Kb LCMV gp34-41 Tetramer-AVYNFATC-APC | 2018/02/14 | MBL |
| TS-5018-1C | T-Select H-2Db RSV M187-195 Tetramer-NAITNAKII-PE | 2018/02/14 | MBL |
| TS-5018-2C | T-Select H-2Db RSV M187-195 Tetramer-NAITNAKII-APC | 2018/02/14 | MBL |
| TS-M106-2 | HLA-B*35:01 HIV nef 74-81 Tetramer-VPLRPMTY-APC | 2018/02/14 | MBL |
| TS-0011-1C | T-Select HLA-A*02:01 EBV BMLF1 Tetramer-GLCTLVAML-PE | 2017/12/25 | MBL |
| TS-0022-2C | T-Select HLA-A*24:02 HBV core Tetramer-EYLVSFGVW-APC | 2017/12/25 | MBL |
| TS-0029-2C | T-Select HLA-A*02:01 Negative Tetramer-APC | 2017/12/25 | MBL |
| TS-5002-1C | T-Select H-2Db LCMV gp33 Tetramer-KAVYNFATC-PE | 2017/12/25 | MBL |
| TS-M039-1 | HLA-A*02:01 HCV NS3 1073-1081 Tetramer-CINGVCWTV-PE | 2017/12/25 | MBL |
| TS-M040-1 | HLA-A*02:01 HCV NS3 1406-1415 Tetramer-KLVALGINAV-PE | 2017/12/25 | MBL |
| TS-M047-1 | HLA-A*02:01 HPV16 E6 Tetramer-KLPQLCTEL-PE | 2017/12/25 | MBL |
| TS-M047-2 | HLA-A*02:01 HPV16 E6 Tetramer-KLPQLCTEL-APC | 2017/12/25 | MBL |
| TS-M051-2 | HLA-A*02:01 HBV env 335-343 Tetramer-WLSLLVPFV-APC | 2017/12/25 | MBL |
| TS-M053-1 | HLA-A*02:01 HBV pol Tetramer-FLLSLGIHL-PE | 2017/12/25 | MBL |
| TS-M107-1 | HLA-A*02:01 PAP 299-307 Tetramer-ALDVYNGLL-PE | 2017/12/25 | MBL |
| TS-M107-2 | HLA-A*02:01 PAP 299-307 Tetramer-ALDVYNGLL-APC | 2017/12/25 | MBL |
| TS-M534-2 | H-2Kd Influenza NP Tetramer-TYQRTRALV-APC | 2017/12/25 | MBL |
| TS-M562-1 | H-2Kb mTERT Tetramer-VGRNFTNL-PE | 2017/12/25 | MBL |
| TB-0165-2 | HLA-A*02:01 Influenza M1 Tetramer-ILGFVFTLTV-APC | 2017/11/24 | MBLI |
| TB-0165-1 | HLA-A*02:01 Influenza M1 Tetramer-ILGFVFTLTV-PE | 2017/11/24 | MBLI |
| TB-0117-2 | HLA-A*24:02 EBV LMP-2 Tetramer-TYGPVFMCL-APC | 2017/11/24 | MBLI |
| TB-0117-1 | HLA-A*24:02 EBV LMP-2 Tetramer-TYGPVFMCL-PE | 2017/11/24 | MBLI |
| TS-M553-2 | H-2Kd NRP-V7 Tetramer-KYNKANVFL-APC | 2017/11/20 | MBL |
| TS-0011-2C | T-Select HLA-A*02:01 EBV BMLF1 Tetramer-GLCTLVAML-APC | 2017/11/10 | MBL |
| TS-M537-1 | H-2Kb HBV core Tetramer-MGLKFRQL-PE | 2017/11/10 | MBL |
| TS-0008-2C | T-Select HLA-A*02:01 HIV pol Tetramer-ILKEPVHGV-APC | 2017/10/16 | MBL |
| TS-M037-1 | HLA-B*35:01 EBV BZLF1 54-64 Tetramer-EPLPQGQLTAY-PE | 2017/10/16 | MBL |
| TS-M051-1 | HLA-A*02:01 HBV env 335-343 Tetramer-WLSLLVPFV-PE | 2017/10/16 | MBL |
| TS-M105-1 | HLA-A*02:01 NY-ESO-1 C9V Tetramer-SLLMWITQV-PE | 2017/10/16 | MBL |
| TS-M105-2 | HLA-A*02:01 NY-ESO-1 C9V Tetramer-SLLMWITQV-APC | 2017/10/16 | MBL |
| TS-5008-2C | T-Select H-2Db HPV16 E7 Tetramer-RAHYNIVTF-APC | 2017/08/31 | MBL |
| TS-M011-1 | T-Select HLA-A*02:01 NY-ESO-1 Tetramer-SLLMWITQC-PE | 2017/08/01 | MBL |
| TS-M037-2 | HLA-B*35:01 EBV BZLF1 54-64 Tetramer-EPLPQGQLTAY-APC | 2017/08/01 | MBL |
| TS-M120-2 | HLA-A*02:01 PSA141-150 Tetramer-FLTPKKLQCV-APC | 2017/08/01 | MBL |
| TS-M122-1 | HLA-A*02:01 VZV IE62 Tetramer-ALWALPHAA-PE | 2017/08/01 | MBL |
| TS-M122-2 | HLA-A*02:01 VZV IE62 Tetramer-ALWALPHAA-APC | 2017/08/01 | MBL |
| TS-0009-2C | T-Select HLA-A*02:01 Mart-1 Tetramer-ELAGIGILTV-APC | 2017/06/01 | MBL |
| TS-5004-1C | T-Select H-2Kb TRP-2 Tetramer-SVYDFFVWL-PE | 2017/06/01 | MBL |
| TS-5004-2C | T-Select H-2Kb TRP-2 Tetramer-SVYDFFVWL-APC | 2017/06/01 | MBL |
| TS-M053-2 | HLA-A*02:01 HBV pol Tetramer-FLLSLGIHL-APC | 2017/06/01 | MBL |
| TS-M070-1 | HLA-A*02:01 MAGE-A1 Tetramer-KVLEYVIKV-PE | 2017/06/01 | MBL |
| TS-M099-1 | HLA-B*07:02 CMV pp65 Tetramer-RPHERNGFTVL-PE | 2017/06/01 | MBL |
| TS-M099-2 | HLA-B*07:02 CMV pp65 Tetramer-RPHERNGFTVL-APC | 2017/06/01 | MBL |
| TS-M534-1 | H-2Kd Influenza NP Tetramer-TYQRTRALV-PE | 2017/06/01 | MBL |
| TS-M552-1 | H-2Kd IGRP Tetramer-VYLKTNVFL-PE | 2017/06/01 | MBL |
| TS-0009-1C | T-Select HLA-A*02:01 Mart-1 Tetramer-ELAGIGILTV-PE | 2017/04/18 | MBL |
| TS-M011-2 | T-Select HLA-A*02:01 NY-ESO-1 Tetramer-SLLMWITQC-APC | 2017/04/18 | MBL |
| TS-M039-2 | HLA-A*02:01 HCV NS3 1073-1081 Tetramer-CINGVCWTV-APC | 2017/04/18 | MBL |
| TS-M057-2 | HLA-A*02:01 CMV IE1 316-324 Tetramer-VLEETSVML-APC | 2017/04/18 | MBL |
| TS-M070-2 | HLA-A*02:01 MAGE-A1 Tetramer-KVLEYVIKV-APC | 2017/04/18 | MBL |
| TS-M074-1 | HLA-A*01:01 MAGE-A3 Tetramer-EVDPIGHLY-PE | 2017/04/18 | MBL |
| TS-M074-2 | HLA-A*01:01 MAGE-A3 Tetramer-EVDPIGHLY-APC | 2017/04/18 | MBL |
| TS-M106-1 | HLA-B*35:01 HIV nef 74-81 Tetramer-VPLRPMTY-PE | 2017/04/18 | MBL |
| TS-M538-1 | H-2Kb VACV B8R Tetramer-TSYKFESV-PE | 2017/04/18 | MBL |
| TS-M538-2 | H-2Kb VACV B8R Tetramer-TSYKFESV-APC | 2017/04/18 | MBL |
| TS-M539-1 | H-2Db SV40 large T Ag 206-215 Tetramer-SAINNYAQKL-PE | 2017/04/18 | MBL |
| TS-M539-2 | H-2Db SV40 large T Ag 206-215 Tetramer-SAINNYAQKL-APC | 2017/04/18 | MBL |
| TS-M547-1 | H-2Kd Plasmodium CSP Tetramer-SYVPSAEQI-PE | 2017/04/18 | MBL |
| TS-M547-2 | H-2Kd Plasmodium CSP Tetramer-SYVPSAEQI-APC | 2017/04/18 | MBL |
| TS-M553-1 | H-2Kd NRP-V7 Tetramer-KYNKANVFL-PE | 2017/04/18 | MBL |
| TS-0013-2C | T-Select HLA-A*02:01 gp100 (mutant) Tetramer-IMDQVPFSV-APC | 2017/03/27 | MBL |
| TS-0014-2C | T-Select HLA-A*02:01 gp100 (wild) Tetramer-ITDQVPFSV-APC | 2017/03/27 | MBL |
| TS-0022-1C | T-Select HLA-A*24:02 HBV core Tetramer-EYLVSFGVW-PE | 2017/03/27 | MBL |
| TS-0025-2C | T-Select HLA-B*07:02 CMV pp65 Tetramer-TPRVTGGGAM-APC | 2017/03/27 | MBL |
| TS-0035-1C | T-Select HLA-A*02:01 gp100 154-162-KTWGQYWQV-PE | 2017/03/27 | MBL |